12 results
diagnosis differential dm2 hyperkalemia causes high management nephrology agonists binder comparison diabetic dpp4 druginduced drugs eudka euglycemic glp1 hypomagnesemia hypomg
Mechanisms of Drug-Induced Hyperkalemia • Direct renin inhibitor (Aliskiren) • Renin release inhibition (NSAIDs, Beta-Blockers)
• Direct renin inhibitor ... • Calcineurin Inhibitors ... differential #diagnosis #pathophysiology ... #pharmacology # ... potassium #medications
Mechanism of Action for Common Diabetes Medications • SGLT2i (Dapagliflozin) • TZD (Pioglitazone) • Biguanides (Metformin)
Action for Common Diabetes ... Medications ... #Medications #pharmacology ... #pathophysiology ... #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... #Renal #Dosing ... #Pharmacology #Management ... #Diabetes #DM2 ... #Endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Sulfonylurea, TZD, DPP-4 inhibitor ... α-glucosidase inhibitor ... #pharmacology # ... comparison #table #endocrinology
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... medications, with ... #Pharmacology # ... Medications #DM2 ... #Diabetes #Endocrinology
Euglycemic Diabetic Ketoacidosis (EuDKA) SGLT2 Inhibitors Increasing Indications Significant Adverse Drug Effects Definition of EuDKA • Metabolic acidosis with pH
Euglycemic Diabetic ... (EuDKA) SGLT2 Inhibitors ... Increasing Indications ... level < 200 mg/dL Pathophysiology ... diagnosis #management #endocrinology
Causes of Hypomagnesemia Redistribution: - IV glucose - Correction of diabetic ketoacidosis - IV hyperalimentation - Refeeding
Correction of diabetic ... osmotic diuresis - Potassium ... - Proton pump inhibitors ... #differential #medications ... #drugs #pharmacology
Veltassa (Patiromer) MECHANISM: Potassium Binder INDICATION: Treatment of Hyperkalemia FORMULATION: Powder for oral suspension DOSING: 8.4
) MECHANISM: Potassium ... oral suspension DOSING ... with CKD, HF, or diabetes ... ACE inhibitors, ... #Hyperkalemia #Pharmacology
GLP-1 Agonists Adlyxin (Lixisenatide) Daily Bydureon (Exenatide ER) Weekly Ozempic (Semaglutide) Weekly Trulicity (Dulaglutide) Weekly Victoza (Liraglutide) Daily
commonly used medications ... to treat Type 2 Diabetes ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes ... #DM2 #Endocrinology
Hyperkalemia - Differential Diagnosis Framework PseudoHyperkalemia: • Lab error • Traumatic venipuncture • Hemolysis, thrombocytosis, leukocytosis •
Clenching of fist during ... NSAIDs • ACE Inhibitors ... • Recent IV potassium ... (Uncontrolled diabetes ... Medications 2.
No results found for "LMWH pharmacology medications pathophysiology endocrinology diabetes dosing inhibitors potassium"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #LMWH #pharmacology #medications #pathophysiology #endocrinology #diabetes #dosing #inhibitors #potassium